MedTrace Logo

Group Therapy for Primary Breast Cancer

NCT00220792 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2024-08-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether women with primary breast cancer who were randomly assigned to receive a brief group therapy would show a greater reduction in mood disturbance over time compared to those randomized to the control condition. We also hypothesized that women who were highly distressed at baseline would show the greatest benefit from participating in a support group, and that therapists with more training and experience would be most effective in reducing distress.

Conditions

Interventions

BEHAVIORAL

Brief supportive-expressive group therapy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Cummings Foundation

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • David Spiegel, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-06-30
Completion
1998-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00220792 on ClinicalTrials.gov